Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung
Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin - ScienceDirect
Malignant paraganglioma of the posterior mediastinum: A case report with genetic analysis
Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung
Malignant paraganglioma of the posterior mediastinum: A case report with genetic analysis
Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin - ScienceDirect
WO2006066915A1 - Use of cyfra 21-1 as a marker for colorectal cancer - Google Patents
WO2006066915A1 - Use of cyfra 21-1 as a marker for colorectal cancer - Google Patents
Clinical equivalence of two cytokeratin markers in non-small cell lung cancer *: a study of tissue polypeptide antigen and cytokeratin 19 fragments - Document - Gale Academic OneFile
WO2006066915A1 - Use of cyfra 21-1 as a marker for colorectal cancer - Google Patents
Clinical equivalence of two cytokeratin markers in non-small cell lung cancer *: a study of tissue polypeptide antigen and cytokeratin 19 fragments - Document - Gale Academic OneFile
WO2006066915A1 - Use of cyfra 21-1 as a marker for colorectal cancer - Google Patents
Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung
Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung
PDF) CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European Multicentre Evaluation. CYFRA 21-1 Multicentre Study Group
PDF) CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European Multicentre Evaluation. CYFRA 21-1 Multicentre Study Group
PDF) CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European Multicentre Evaluation. CYFRA 21-1 Multicentre Study Group
Clinical equivalence of two cytokeratin markers in non-small cell lung cancer *: a study of tissue polypeptide antigen and cytokeratin 19 fragments - Document - Gale Academic OneFile
PDF) Mediastinal Yolk Sac Tumor Producing Protein Induced by Vitamin K Absence or Antagonist-II
WO2006066915A1 - Use of cyfra 21-1 as a marker for colorectal cancer - Google Patents
Malignant paraganglioma of the posterior mediastinum: A case report with genetic analysis. - Abstract - Europe PMC
Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin - ScienceDirect
Clinical equivalence of two cytokeratin markers in non-small cell lung cancer *: a study of tissue polypeptide antigen and cytokeratin 19 fragments - Document - Gale Academic OneFile
Malignant paraganglioma of the posterior mediastinum: A case report with genetic analysis
